We are live on ! Find out more
ASTH icon

Astrana Health

130 hedge funds and large institutions have $656M invested in Astrana Health in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,047% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $211K

31% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 42

1.19% more ownership

Funds ownership: 34.88%36.07% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 133130 (-3)

10% less capital invested

Capital invested by funds: $730M → $656M (-$74.2M)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

Holders
130
Holders Change
-3
Holders Change %
-2.26%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
55
Reduced
42
Closed
16
Calls
$17.2M
Puts
$211K
Net Calls
+$17M
Net Calls Change
+$5.56M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
76
Arizona State Retirement System
Arizona
$382K +$20.4K +594 +5%
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$366K -$92.9K -2,710 -19%
Two Sigma Investments
78
Two Sigma Investments
New York
$351K
HW
79
Hancock Whitney
Mississippi
$324K -$162K -4,738 -32%
Los Angeles Capital Management
80
Los Angeles Capital Management
California
$319K +$6K +175 +2%
AG
81
Algert Global
California
$288K +$18.9K +550 +6%
MOACM
82
Mutual of America Capital Management
New York
$249K -$7.89K -230 -3%
Envestnet Asset Management
83
Envestnet Asset Management
Illinois
$245K +$266K +7,745 New
Handelsbanken Fonder
84
Handelsbanken Fonder
Sweden
$228K
QT
85
Quantbot Technologies
New York
$223K +$242K +7,069 New
Allianz Asset Management
86
Allianz Asset Management
Germany
$218K -$295K -8,600 -55%
GCP
87
GSA Capital Partners
United Kingdom
$218K +$236K +6,896 New
ECM
88
Everence Capital Management
Indiana
$217K
ProShare Advisors
89
ProShare Advisors
Maryland
$209K +$33.4K +975 +17%
LTAS
90
Linden Thomas Advisory Services
North Carolina
$200K +$217K +6,335 New
Zurich Cantonal Bank
91
Zurich Cantonal Bank
Switzerland
$200K +$71.4K +2,081 +49%
Public Employees Retirement Association of Colorado
92
Public Employees Retirement Association of Colorado
Colorado
$180K
SDIC
93
South Dakota Investment Council
South Dakota
$166K -$3.43K -100 -2%
ACM
94
Aquatic Capital Management
Illinois
$133K +$51.4K +1,500 +56%
AIP
95
Ameritas Investment Partners
Nebraska
$112K +$20.4K +594 +20%
SOW
96
State of Wyoming
Wyoming
$99.2K +$108K +3,138 New
KBC Group
97
KBC Group
Belgium
$95K -$13.7K -400 -12%
MLICM
98
Metropolitan Life Insurance Company (MetLife)
New York
$74K +$8.09K +236 +11%
Allspring Global Investments
99
Allspring Global Investments
North Carolina
$71.6K -$1.44K -42 -2%
TRCT
100
Tower Research Capital (TRC)
New York
$68.6K +$40.2K +1,171 +117%

ASTH Hedge Fund Activity: Q2 2023 in Review

130 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2023, worth a combined $656M — down 10% from $730M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ASTH and 13 opened new positions — a net loss of 3 holders — while 42 trimmed existing stakes and 55 added.

The largest buyer was BlackRock, adding an estimated $7.57M. The largest seller was Axa, cutting an estimated $1.98M.

  • 130 institutional investors held Astrana Health (ASTH) as of Q2 2023, down from 133 in Q1 2023.
  • Funds reported $656M of Astrana Health stock for Q2 2023, down 10% quarter-over-quarter.
  • 13 funds opened new Astrana Health positions in Q2 2023 and 16 closed out, a net change of -3 holders.
  • The largest Astrana Health buyer in Q2 2023 was BlackRock, an estimated $7.57M added.
  • The largest Astrana Health seller in Q2 2023 was Axa, an estimated $1.98M sold.

Based on aggregated 13F filings for Q2 2023.